Skip to main content
. 2023 Sep 15;51(12):3268–3279. doi: 10.1177/03635465231197374

Table 6.

Frequency of HS and MC Patients Achieving MCID and PASS Thresholds a

MCID PASS
Threshold HS Cohort % Achieved MC Cohort % Achieved P Threshold HS Cohort % Achieved MC Cohort % Achieved P
12 Months n = 65 n = 76 n = 65 n = 76
 mHHS Δ >6.9 87.7 81.3 .303 >84.8 44.6 61.3 .048 b
 HOS-ADL Δ >8.8 67.7 68.4 .926 >89.7 49.2 81.6 <.001 b
 HOS-SS Δ >13.9 78.5 73.3 .480 >72.2 47.7 68.0 .015 b
 NAHS Δ >9.1 83.1 67.1 .030 b >81.9 64.6 86.8 .002 b
 iHOT-33 Δ >15.1 75.0 75.0 .999 >69.1 54.7 80.3 .001 b
24 Months n = 66 n = 77 n = 66 n = 77
 mHHS Δ >9.2 84.9 83.1 .779 >83.3 59.1 75.3 .038 b
 HOS-ADL Δ >9.7 62.1 68.8 .399 >88.2 65.2 81.8 .023 b
 HOS-SS Δ >14.3 78.8 77.9 .900 >76.4 59.1 68.8 .225
 NAHS Δ >8.3 83.3 80.5 .664 >85.6 60.6 80.5 .009 b
 iHOT-33 Δ >13.9 80.3 84.4 .519 >72.2 54.6 72.7 .024 b
a

HOS-ADL, Hip Outcome Score–Activities of Daily Living; HOS-SS, Hip Outcome Score–Sports Subscale; HS, hip-spine; iHOT-33, International Hip Outcome Tool–33; MC, matched control; MCID, minimal clinically important difference; mHHS, modified Harris Hip Score; NAHS, Non-Arthritic Hip Score; PASS, Patient Acceptable Symptom State.

b

A significant difference between groups.